Trajan acquires blood testing business MyHealthTest

Trajan Scientific Australia Pty Ltd

Thursday, 22 April, 2021

Trajan acquires blood testing business MyHealthTest

Trajan Scientific and Medical has completed its acquisition of the MyHealthTest blood testing service for an undisclosed sum, boosting the company’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Trajan is a privately owned Australian company that provides analytical and life science instruments, devices and components to enable more selective, sensitive and specific measurement and analysis of biological, environmental and food samples.

MyHealthTest, meanwhile, is a Canberra-based healthcare company that delivers analytical measurement services, allowing people to proactively work towards managing their own wellbeing. The company has expertise in dried blood spot (DBS) technology, which allows people to take samples of their own blood at home or in the workplace for analysis at MyHealthTest’s NATA-certified pathology laboratory.

MyHealthTest also provides a range of clinical laboratory research services to the health industry and research institutions. It has significant experience in the development, validation and verification of immunoassay (ELISA, time-resolved fluorescence), liquid chromatography–mass spectrometry (LC-MS) and biochemistry methods for clinical use.

The acquisition of MyHealthTest comes after Trajan recently took 100% ownership of Trajan Nutrition, a nutritional testing business that had been operated as a joint venture, and commenced expansion of Trajan Nutrition’s Melbourne laboratory to provide broader analytical services. Over the next six months, Trajan will combine the Trajan Nutrition testing facility with MyHealthTest to form a new business unit: Trajan Analytical Services.

“The acquisition of MyHealthTest is the next step for Trajan establishing the utility of its new and emerging disruptive tools for personalised preventative health care and data-based decision-making,” said Trajan CEO Stephen Tomisich.

“By combining MyHealthTest with Trajan Nutrition, we are putting together the first building blocks in a future global Trajan Analytical Services business unit. It’s all part of our vision to embrace a world that delivers personalised, preventative health care through the empowerment of the individual.

“You can only have preventative health care if you measure the healthy and are able to understand the condition of the healthy, hence our intense focus on micro-sampling tools and laboratory automation that can generate data. It’s the data that ultimately is going to be interpreted to provide a view of someone’s health trajectory, and this acquisition strengthens Trajan’s capabilities to provide leadership in this space.”

Trajan has retained the key members of the MyHealthTest team, with MyHealthTest Chief Scientific Officer and General Manager Belinda Whittle joining Trajan as General Manager of the new Trajan Analytical Services business unit.

“I am excited to be joining the Trajan team, leaders in providing essential products and analytical services to the scientific and healthcare communities,” Whittle said. “MyHealthTest’s service is synergistic with Trajan’s vision to positively impact human wellbeing and empower individuals to take control of their health.

“I look forward to expanding the number of tests available, combining Trajan’s unique sampling technologies. The new Trajan Analytical Services unit will be well placed to leverage increasing global demand for high-quality laboratory testing, not only for disease but also for nutrition and wellbeing.”

Image credit: ©

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

NSW Govt invests in Sydney Biomedical Accelerator and more

Dominic Perrottet has announced a $270.3m boost to biomedical research in the 2022–23 NSW...

Call for mandatory research integrity training in Aus

The results of the first national survey to investigate research integrity in Australia indicate...

NSW Govt commits $119 million to RNA R&D

The NSW Government will accelerate the translation of local RNA research into new products,...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd